BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18192077)

  • 1. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
    Behar PR; Teixeira PJ; Fachel JM; Kalil AC
    J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
    Demir S; Soysal A; Bakir M; Kaufmann ME; Yagci A
    J Paediatr Child Health; 2008 Oct; 44(10):548-53. PubMed ID: 18557808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center.
    Filozov A; Visintainer P; Carbonaro C; Aguero-Rosenfeld M; Wormser GP; Montecalvo MA
    Am J Infect Control; 2009 Nov; 37(9):723-8. PubMed ID: 19501935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.
    Gundes S; Arisoy AE; Kolayli F; Karaali E; Turker G; Sanic A; Arisoy ES; Vahaboglu H
    New Microbiol; 2005 Jul; 28(3):231-6. PubMed ID: 16240695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
    Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N
    J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH; Su LH; Tang YF; Liu JW
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
    Bennett JW; Robertson JL; Hospenthal DR; Wolf SE; Chung KK; Mende K; Murray CK
    J Am Coll Surg; 2010 Sep; 211(3):391-9. PubMed ID: 20800197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon.
    Kanafani ZA; Mehio-Sibai A; Araj GF; Kanaan M; Kanj SS
    Am J Infect Control; 2005 Aug; 33(6):326-32. PubMed ID: 16061138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
    Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
    Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
    Memon JI; Rehmani RS; Ahmed MU; Elgendy AM; Nizami IY
    Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
    Tumbarello M; Spanu T; Sanguinetti M; Citton R; Montuori E; Leone F; Fadda G; Cauda R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):498-504. PubMed ID: 16436702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
    Cantey JB; Sreeramoju P; Jaleel M; Treviño S; Gander R; Hynan LS; Hill J; Brown C; Chung W; Siegel JD; Sánchez PJ
    J Pediatr; 2013 Sep; 163(3):672-9.e1-3. PubMed ID: 23582136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
    Kritsotakis EI; Tsioutis C; Roumbelaki M; Christidou A; Gikas A
    J Antimicrob Chemother; 2011 Jun; 66(6):1383-91. PubMed ID: 21454344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.